Neovascularization, Pathologic - 25 Studies Found
Completed |
: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial : Choroidal Neovascularization : 2006-08-09 :
|
Completed |
: Bevacizumab for the Treatment of Corneal Neovascularization : Corneal Neovascularization : 2009-10-08 : Drug: Bevacizumab Topical 10 mg/cc or subconjunctival 2.5 mg/0.1cc |
Recruiting |
: 68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis : Pathological Angiogenesis : 2016-01-24 :
|
Completed |
: The Effect of Bevacizumab on Corneal Neovascularization : Corneal Neovascularization : 2008-11-22 : Drug: Bevacizumab subconjunctival injection of 1.25 mg bevacizumab and had a follow-up of at least 2 mon |
Completed |
: Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery : Corneal Neovascularization : 2008-10-07 : Drug: Ranibizumab 0.5mg subconjunctival dose of ranibizumab 3 days prior to corneal transplantation and |
Completed |
: Treatment of Corneal Neovascularization With Topical Pazopanib : Corneal Neovascularization : 2010-11-22 : Drug: Pazopanib (5mg/ml) Topical pazopanib, 4 times per day for 3 weeks |
Completed |
: Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization : Corneal Neovascularization : 2007-11-07 : Drug: Bevacizumab (Avastin) One dose of 0.1cc of subconjunctival Bevacizumab was applied |
Terminated |
: Topical IL-1-Ra for Treatment of Corneal Neovascularization : Corneal Neovascularization : 2009-06-04 :
|
Not yet recruiting |
: Strategies for Management of Corneal Neovascularisation : Corneal Neovascularisation : 2015-10-27 :
|
Completed |
: Topical Avastin for Treatment of Corneal Neovascularization : Corneal Neovascularization : 2007-11-14 : Drug: Topical Avastin 1% Avastin (bevacizumab) 1% Ot |